Trump picks Fiserv CEO Bisignano to head the Social Security Administration-February 2024-www.financetom.com

Trump picks Fiserv CEO Bisignano to head the Social Security Administration

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Trump picks Fiserv CEO Bisignano to head the Social Security Administration

Dec 4, 2024 5:40 PM

WASHINGTON, Dec 4 (Reuters) - U.S. President-elect

Donald Trump said on Wednesday he has chosen Fiserv ( FI ) CEO Frank

Bisignano to head the Social Security Administration.

Previous page： Fine Organics IPO opens today, subscription to close on June 22 Next page： Finally, Google launches a podcast app for Android with personalised recommendations

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Fine Organics IPO opens today, subscription to close on June 22

Jun 20, 2018

Fine Organics IPO has opened for subscription today. The company is the largest manufacturer of oleo-chemical based additives in India and a strong player globally in this industry. Tushar Shah, CFO of Fine Organics shared his outlook.

Finally, Google launches a podcast app for Android with personalised recommendations

Jun 20, 2018

The app, called simply Google Podcasts, will use Google’s recommendation algorithms to gauge users’ listening habits and hook them up with podcasts they are most likely to enjoy.

Strong demand coming up but acquisitions will impact the topline, says Motherson Sumi

Jun 20, 2018

Motherson Sumi has a strong demand but acquisitions will impact the topline, said Vivek Chaand Sehgal, chairman of the company....

United Phosphorus looks to buy billionaire investor-backed Platform unit, says report

Jun 20, 2018

The development comes after Platform, the chemical maker backed by Bill Ackman's Pershing Square Capital Management said on Monday that it had entered in to negotiations for the sale of Arysta LifeScience.